This assay is only available within the United States of America
Laboratory Contact Information
Address
357 Riverside Drive
Suite 1001
Franklin, TN 37064
Suite 1001
Franklin, TN 37064
Phone Number
(615) 282-8824
Hours of Operation
Monday – Friday
7:00am – 4:00pm
7:00am – 4:00pm
Email
USsupport@dxcover.com
- Test Code:
- DXCB
- Test Name:
- Dxcover Brain
- CPT Codes:
- TBD- To be determined
- Methodology:
- Proprietary technology developed by Dxcover using an Attenuated Total Reflectance (ATR) - Fourier Transform Infrared (FTIR) Spectrometer, coupled with a Dxcover® Autosampler; spectral data output is analyzed by the Dxcover® Brain Cancer Diagnostic Software.
- Department:
- Chemistry
- Specimen Type:
- Serum
- Specimen Container:
- Sarstedt S-Monovette® Serum Gel tubes with clotting activator/gel and brown-topped screw cap or BD Vacutainer® Serum Seperated Tubes
- Specimen Volume:
- 0.5uL-1.5uL Serum (minimum 0.5uL)
- Specimen Stability:
-
- Ambient (15°C-25°C): 8 hours
- Refrigerated (+2 – +8°C): 24 hours
- Frozen (-80)°C: 30 days
- Specimen Preparation:
-
Freshy drawn specimens must be stored refrigerated (+2 – +8°C) and left upright for at least 30 minutes (up to a maximum of 24 hours from the time of blood collection) before centrifugation.
Specimens should be centrifuged at a minimum centrifugal speed of 2200 x g for 15 minutes. Serum should be distributed into 1 aliquot in the provided 2mL cryovial with proper identification. Follow manufacturer’s instructions for collection tube handling.
- Storage/Transport Temperature:
- Frozen (Ice packs or dry ice packaging must be used to maintain the sample frozen during transport.)
- Unacceptable Conditions:
- Non-frozen serum; Plasma samples; Whole blood samples; Incorrect specimen container (i.e., not a 2mL cryovial) (e.g., microcentrifuge tube, conical tube); Damaged or compromised 2mL cryovial (e.g., cracked vial, loose screwcap); Quantity not sufficient
- Additional Notes:
-
Patients must have symptoms commonly associated with brain cancer (e.g., headache, migraine, memory loss etc.).
Test results will be: Elevated Risk or Low Risk
- Elevated Risk:
- This result indicates detection of blood-based spectral features associated with an elevated risk of brain cancer relative to the test’s validated classification threshold. Timely adjunctive clinical and diagnostic assessments are recommended.
- Low Risk:
- This result indicates that blood-based spectral features associated with brain cancer were not detected above the test’s validated classification threshold.
- Test Not Performed:
- Unable to provide a result, resubmit new specimen for analysis.
- Turn Around Time:
- 1-3 Business Days (upon receipt of the specimen)